VEGF receptor — Drug Target
All drugs that target VEGF receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Anti-angiogenic agent / VEGF inhibitor · VEGF inhibitor
Phase 3 pipeline (2)
- HRS-4357 injection · Jiangsu HengRui Medicine Co., Ltd. · Anti-angiogenic agent / VEGF inhibitor · Oncology
HRS-4357 is an anti-angiogenic agent that inhibits vascular endothelial growth factor (VEGF) signaling to suppress tumor blood vessel formation. - HR17031 injection · Jiangsu HengRui Medicine Co., Ltd. · VEGF inhibitor · Oncology
HR17031 is an anti-angiogenic agent that inhibits vascular endothelial growth factor (VEGF) signaling to suppress tumor blood vessel formation.